Anrikefon

DRUG4 trials

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University, Zhujiang Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Affiliated Hospital of Guangdong Medical University

Conditions

Gallbladder PolypsGallbladder StonesKidney Diseases, ChronicOphthalmic SurgeryOpioid AnalgesiaPatients Who Undergo PancreaticoduodenectomyPostoperative Pain ManagementPruritus Chronic

Phase 2

Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery.

RecruitingNCT07514637

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPatients Who Undergo Pancreaticoduodenectomy

Start: 2025-11-25End: 2026-03-31Target: 35Updated: 2026-04-07

A Study on the Efficacy and Safety of Anrikefon for Postoperative Pain Relief Following Laparoscopic Cholecystectomy

Not yet recruitingNCT07741188

Affiliated Hospital of Guangdong Medical UniversityGallbladder Stones, Gallbladder Polyps

Start: 2026-09-01End: 2028-12-31Target: 144Updated: 2026-08-03

Phase 4

Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery

RecruitingNCT07269106

Zhongshan Ophthalmic Center, Sun Yat-sen UniversityOphthalmic Surgery, Postoperative Pain Management, Opioid Analgesia

Start: 2026-01-22End: 2027-12-31Target: 204Updated: 2026-04-01

Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP

RecruitingNCT07380113

Zhujiang HospitalPruritus Chronic, Kidney Diseases, Chronic, Renal Insufficiency, Chronic +3

Start: 2026-06-22End: 2027-12-31Target: 50Updated: 2026-08-25